Cargando…
H3K4 trimethylation regulates cancer immunity: a promising therapeutic target in combination with immunotherapy
With the advances in cancer immunity regulation and immunotherapy, the effects of histone modifications on establishing antitumor immunological ability are constantly being uncovered. Developing combination therapies involving epigenetic drugs (epi-drugs) and immune checkpoint blockades or chimeric...
Autores principales: | Xiao, Chu, Fan, Tao, Zheng, Yujia, Tian, He, Deng, Ziqin, Liu, Jingjing, Li, Chunxiang, He, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10414074/ https://www.ncbi.nlm.nih.gov/pubmed/37553181 http://dx.doi.org/10.1136/jitc-2022-005693 |
Ejemplares similares
-
H3K36 trimethylation-mediated biological functions in cancer
por: Xiao, Chu, et al.
Publicado: (2021) -
Glycolysis in tumor microenvironment as a target to improve cancer immunotherapy
por: Xiao, Chu, et al.
Publicado: (2022) -
KLF12 overcomes anti-PD-1 resistance by reducing galectin-1 in cancer cells
por: Zheng, Yujia, et al.
Publicado: (2023) -
Transmembrane Protein-Based Risk Model and H3K4me3 Modification Characteristics in Lung Adenocarcinoma
por: Fan, Tao, et al.
Publicado: (2022) -
H3K4me3-related lncRNAs signature and comprehensive analysis of H3K4me3 regulating tumor immunity in lung adenocarcinoma
por: Fan, Tao, et al.
Publicado: (2023)